SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital
by Samia A. Girgis, Hala M. Hafez, Hoda Ezz Elarab, Basma Sherif, Moshira H. Sabry, Iman Afifi, Fatma Elzahraa Hassan, Amira Reda, Shaimaa Elsayed, Asmaa Mahmoud, Petra Habeb, Ihab S. Habil, Rasha S. Hussein, Isis M. Mossad, Ossama Mansour, Ashraf Omar, Ayman M. Saleh, Mahmoud El-Meteini
BackgroundResearch has revealed that asymptomatic and pre-symptomatic infections are important contributors to the transmission of SARS-CoV-2 in populations. In Egypt, the true prevalence of infections is veiled due to the low number of screening tests. The aim of this study was to determine the SARS-CoV-2 PCR positivity rate as well the seroprevalence of the SARS-CoV-2 antibodies before the ultimate development of a second wave of the epidemic in Cairo, Egypt.
MethodsOur study was carried out between May 5 and the end of October 2020. It included all patients requiring admission to Ain Shams University hospitals. An interview questionnaire was used to collect demographic and clinical data. Laboratory tests for all participants included RT-PCR and total antibody assay for SARS-CoV-2.
ResultsA total of 4,313 subjects were enrolled in our study, with females representing 56% of the sample. Adults and middle-aged individuals represented around 60% of the study sample. The positivity rate of SARS-CoV-2 PCR was 3.84% (95% CI 3.29–4.48), and the SARS-CoV-2 antibody seroprevalence was 29.82% (95% CI: 28.16–31.51). Males showed a higher risk for getting the COVID-19 infection, while middle-age group had significantly higher antibody seroprevalence rates.
ConclusionSARS-CoV-2 infection imposes a high burden on the community as detected by high seroprevalence rates.